We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Four Lots of AstraZeneca’s COVID-19 Vaccine Unearthed at Emergent’s Troubled Baltimore Manufacturing Plant
Four Lots of AstraZeneca’s COVID-19 Vaccine Unearthed at Emergent’s Troubled Baltimore Manufacturing Plant
The FDA has announced that it found four lots of AstraZeneca COVID-19 vaccine drug substance manufactured at the troubled Emergent BioSolutions manufacturing facility in Baltimore, Md., to be acceptable for use for potential export.